Advanced Biomed Inc. (ADVB)
| Market Cap | 562.50M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -4.75M |
| Shares Out | 125.00M |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About ADVB
Advanced Biomed is committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada... [Read more]
Financial Performance
Financial StatementsNews
Advanced Biomed sets IPO terms, which could value the biotech at up to $625 million
Advanced Biomed Inc. ADVB, has set terms for its initial public offering, in which the Taiwan-based biotechnology company focused on treating cancer is looking to raise up to $125 million. The company...
Advanced Biomed IPO Registration Document (S-1)
Advanced Biomed has filed to go public with an IPO on the NASDAQ.